相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anastrozole in Pulmonary Arterial Hypertension A Randomized, Double-Blind, Placebo-controlled Trial
Steven M. Kawut et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2016)
Higher Estradiol and Lower Dehydroepiandrosterone-Sulfate Levels Are Associated with Pulmonary Arterial Hypertension in Men
Corey E. Ventetuolo et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Reversal of right ventricular remodeling by dichloroacetate is related to inhibition of mitochondria-dependent apoptosis
Xiao-Qing Sun et al.
HYPERTENSION RESEARCH (2016)
Antagonism of the thromboxane-prostanoid receptor is cardioprotective against right ventricular pressure overload
James D. West et al.
PULMONARY CIRCULATION (2016)
Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension
Raymond L. Benza et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Oestrogen receptor alpha in pulmonary hypertension
Audrey F. Wright et al.
CARDIOVASCULAR RESEARCH (2015)
Clinical Pharmacokinetics and Pharmacodynamics of the Endothelin Receptor Antagonist Macitentan
P. N. Sidharta et al.
CLINICAL PHARMACOKINETICS (2015)
PATENT PLUS: a blinded, randomised and extension study of riociguat plus sildenafil in pulmonary arterial hypertension
Nazzareno Galie et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension
Vallerie McLaughlin et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Selexipag for the Treatment of Pulmonary Arterial Hypertension
Olivier Sitbon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
N. Galie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Pulmonary arterial hypertension in systemic lupus erythematosus may benefit by addition of immunosuppression to vasodilator therapy: an observational study
Sirisha Kommireddy et al.
RHEUMATOLOGY (2015)
Effects of ranolazine on exercise capacity, right ventricular indices, and hemodynamic characteristics in pulmonary arterial hypertension: a pilot study
Sadiya S. Khan et al.
PULMONARY CIRCULATION (2015)
Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute
Anna R. Hemnes et al.
PULMONARY CIRCULATION (2015)
Effect of imatinib as add-on therapy on echocardiographic measures of right ventricular function in patients with significant pulmonary arterial hypertension
Amil M. Shah et al.
EUROPEAN HEART JOURNAL (2015)
Peripheral Blood Signature of Vasodilator-Responsive Pulmonary Arterial Hypertension
Anna R. Hemnes et al.
CIRCULATION (2015)
Progress in solving the sex hormone paradox in pulmonary hypertension
Tim Lahm et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2014)
Sex-Dependent Influence of Endogenous Estrogen in Pulmonary Hypertension
Kirsty M. Mair et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
The Right Ventricle Explains Sex Differences in Survival in Idiopathic Pulmonary Arterial Hypertension
Wouter Jacobs et al.
CHEST (2014)
Anticoagulation and Survival in Pulmonary Arterial Hypertension Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)
Karen M. Olsson et al.
CIRCULATION (2014)
Beta-adrenergic adaptation in idiopathic dilated cardiomyopathy: differences between children and adults
Steven E. Lipshultz et al.
EUROPEAN HEART JOURNAL (2014)
Dichloroacetate prevents but not reverses the formation of neointimal lesions in a rat model of severe pulmonary arterial hypertension
Bingbing Li et al.
MOLECULAR MEDICINE REPORTS (2014)
The impact of drug-drug interactions on pulmonary arterial hypertension therapy
Rocco Ciraci et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2014)
Benefits of Intensive Treadmill Exercise Training on Cardiorespiratory Function and Quality of Life in Patients With Pulmonary Hypertension
Leighton Chan et al.
CHEST (2013)
Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients Receiving Background Endothelin Receptor Antagonist and Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C2 Study) A Randomized Controlled Trial
Victor F. Tapson et al.
CHEST (2013)
Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension A Randomized, Controlled Trial
Zhi-Cheng Jing et al.
CIRCULATION (2013)
Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension Results of the Randomized IMPRES Study
Marius M. Hoeper et al.
CIRCULATION (2013)
Interaction profile of macitentan, a new non-selective endothelin-1 receptor antagonist, in vitro
Johanna Weiss et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Effects of multikinase inhibitors on pressure overload-induced right ventricular remodeling
Baktybek Kojonazarov et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Updated Treatment Algorithm of Pulmonary Arterial Hypertension
Nazzareno Galie et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Right Heart Adaptation to Pulmonary Arterial Hypertension Physiology and Pathobiology
Anton Vonk-Noordegraaf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Updated Clinical Classification of Pulmonary Hypertension
Gerald Simonneau et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
Tomas Pulido et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
Hossein-Ardeschir Ghofrani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Riociguat for the Treatment of Pulmonary Arterial Hypertension
Hossein-Ardeschir Ghofrani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Impact of switching from epoprostenol to IV treprostinil on treatment satisfaction and quality of life in patients with pulmonary hypertension
O. A. Minai et al.
RESPIRATORY MEDICINE (2013)
Blocking Macrophage Leukotriene B4 Prevents Endothelial Injury and Reverses Pulmonary Hypertension
Wen Tian et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Targeting Energetic Metabolism A New Frontier in the Pathogenesis and Treatment of Pulmonary Hypertension
Rubin M. Tuder et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Evolving Epidemiology of Pulmonary Arterial Hypertension
Thenappan Thenappan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Immune and Inflammatory Cell Involvement in the Pathology of Idiopathic Pulmonary Arterial Hypertension
Rajkumar Savai et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Severe Pulmonary Arterial Hypertension Induced by SU5416 and Ovalbumin Immunization
Shiro Mizuno et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)
Role of Src Tyrosine Kinases in Experimental Pulmonary Hypertension
Soni Savai Pullamsetti et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients on Background Endothelin Receptor Antagonist and/or Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C Study) A Randomized Controlled Trial
Victor E. Tapson et al.
CHEST (2012)
An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry
Raymond L. Benza et al.
CHEST (2012)
Pregnancy outcomes in pulmonary arterial hypertension in the modern management era
Xavier Jais et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension
Gerald Simonneau et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Molecular pathogenesis of pulmonary arterial hypertension
Marlene Rabinovitch
JOURNAL OF CLINICAL INVESTIGATION (2012)
Tadalafil for the Treatment of Pulmonary Arterial Hypertension A Double-Blind 52-Week Uncontrolled Extension Study
Ronald J. Oudiz et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Clinical and Prognostic Relevance of Echocardiographic Evaluation of Right Ventricular Geometry in Patients With Idiopathic Pulmonary Arterial Hypertension
Stefano Ghio et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Plexiform Lesions in Pulmonary Arterial Hypertension Composition, Architecture, and Microenvironment
Danny Jonigk et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Sex Hormones Are Associated with Right Ventricular Structure and Function The MESA-Right Ventricle Study
Corey E. Ventetuolo et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Combination Therapy in Pulmonary Arterial Hypertension: A Meta-Analysis
Yuanyuan Bai et al.
CARDIOLOGY (2011)
Long-term Treatment With Sildenafil Citrate in Pulmonary Arterial Hypertension The SUPER-2 Study
Lewis J. Rubin et al.
CHEST (2011)
Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: The TReprostinil sodium Inhalation Used in the Management of Pulmonary arterial Hypertension (TRIUMPH) study open-label extension
Raymond L. Benza et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2011)
Pharmacogenomics in Pulmonary Arterial Hypertension: Toward a Mechanistic, Target-Based Approach to Therapy
Sami I. Said et al.
Pulmonary Circulation (2011)
Adrenergic Receptor Blockade Reverses Right Heart Remodeling and Dysfunction in Pulmonary Hypertensive Rats
Harm J. Bogaard et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Predicting Survival in Pulmonary Arterial Hypertension Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)
Raymond L. Benza et al.
CIRCULATION (2010)
Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era
Marc Humbert et al.
CIRCULATION (2010)
A Dosing/Cross-Development Study of the Multikinase Inhibitor Sorafenib in Patients With Pulmonary Arterial Hypertension
M. Gomberg-Maitland et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Altered Immune Phenotype in Peripheral Blood Cells of Patients with Scleroderma-Associated Pulmonary Hypertension
Michael G. Risbano et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2010)
Prognostic relevance of the echocardiographic assessment of right ventricular function in patients with idiopathic pulmonary arterial hypertension
Stefano Ghio et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: A placebo-controlled trial
Jagdish Hiremath et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2010)
Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension A Randomized Controlled Clinical Trial
Vallerie V. McLaughlin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
The effects and mechanisms of mycophenolate mofetil on pulmonary arterial hypertension in rats
Yi Zheng et al.
RHEUMATOLOGY INTERNATIONAL (2010)
Phosphodiesterase Type 5 Inhibitors in Pulmonary Arterial Hypertension
David Montani et al.
ADVANCES IN THERAPY (2009)
Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial (vol 149, pg 521, 2008)
G. Simonneau et al.
ANNALS OF INTERNAL MEDICINE (2009)
Ambrisentan Therapy in Patients With Pulmonary Arterial Hypertension Who Discontinued Bosentan or Sitaxsentan Due to Liver Function Test Abnormalities
Michael D. McGoon et al.
CHEST (2009)
The Right Ventricle Under Pressure Cellular and Molecular Mechanisms of Right-Heart Failure in Pulmonary Hypertension
Harm J. Bogaard et al.
CHEST (2009)
Tadalafil Therapy for Pulmonary Arterial Hypertension
Nazzareno Galie et al.
CIRCULATION (2009)
Linking somatic genetic alterations in cancer to therapeutics
Darrin Stuart et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
A meta-analysis of randomized controlled trials in pulmonary arterial hypertension
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2009)
Long-term outcome with intravenous iloprost in pulmonary arterial hypertension
M. M. Hoeper et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Long-Term Ambrisentan Therapy for the Treatment of Pulmonary Arterial Hypertension
Ronald J. Oudiz et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association
Vallerie V. McLaughlin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension
Xavier Jais et al.
ARTHRITIS AND RHEUMATISM (2008)
Combined Tyrosine and Serine/Threonine Kinase Inhibition by Sorafenib Prevents Progression of Experimental Pulmonary Hypertension and Myocardial Remodeling
Martina Klein et al.
CIRCULATION (2008)
Ambrisentan for the treatment of pulmonary arterial hypertension -: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2
Nazzareno Galie et al.
CIRCULATION (2008)
Right ventricular function in cardiovascular disease, Part II - Pathophysiology, clinical importance, and management of right ventricular failure
Francois Haddad et al.
CIRCULATION (2008)
Prostacyclin therapies for the treatment of pulmonary arterial hypertension
M. Gomberg-Maitland et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension
R. T. Schermuly et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Bloodstream infections in patients given treatment with intravenous prostanoids
Alexander J. Kallen et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study):: a double-blind, randomised controlled trial
N. Galie et al.
LANCET (2008)
Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension A Randomized Trial
Gerald Simonneau et al.
ANNALS OF INTERNAL MEDICINE (2008)
Results of European post-marketing surveillance of bosentan in pulmonary hypertension
M. Humbert et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Role of oxidative stress in cardiac hypertrophy and remodeling
Eiki Takimoto et al.
HYPERTENSION (2007)
Alterations of cellular bioenergetics in pulmonary artery endothelial cells
Weiling Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Rapid switch from intravenous epoprostenol to intravenous treprostinil in patients with pulmonary arterial hypertension
Olivier Sitbon et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension
Vallerie V. McLaughlin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Right ventricular function and failure - Report of a National Heart, lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure
Norbert F. Voelkel et al.
CIRCULATION (2006)
Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension
Derliz Mereles et al.
CIRCULATION (2006)
Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension
M. M. Hoeper et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Comparison of phosphodiesterase type 5 (PDE5) inhibitors
P. J. Wright
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2006)
Safety and efficacy of IV treprostinil for pulmonary arterial hypertension - A prospective, multicenter, open-label, 12-week trial
VF Tapson et al.
CHEST (2006)
Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension
S Provencher et al.
GASTROENTEROLOGY (2006)
Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension
M Gomberg-Maitland et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Autoimmunity and pulmonary hypertension: a perspective
MR Nicolls et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Sildenafil citrate therapy for pulmonary arterial hypertension
N Galiè et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Reversal of experimental pulmonary hypertension by PDGF inhibition
RT Schermuly et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension
CF Opitz et al.
EUROPEAN HEART JOURNAL (2005)
Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension
O Sitbon et al.
CIRCULATION (2005)
Combination of bosentan with epoprostenol in pulmonary arterial hypertension:: BREATHE-2
M Humbert et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Pharmacokinetics and steady-state bioequivalence of treprostinil sodium (Remodulin®) administered by the intravenous and subcutaneous route to normal volunteers
K Laliberte et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2004)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis
MS McMurtry et al.
CIRCULATION RESEARCH (2004)
Gene microarray analysis of peripheral blood cells in pulmonary arterial hypertension
TM Bull et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Drug therapy - Pharmacogenomics - Drug disposition, drug targets, and side effects
WE Evans et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Prostacyclin: A vascular mediator
J Vane et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2003)
Inhaled iloprost for severe pulmonary hypertension
H Olschewski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Bosentan therapy for pulmonary arterial hypertension
LJ Rubin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension - A double-blind, randomized, placebo-controlled trial
G Simonneau et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy
TP Cappola et al.
CIRCULATION (2001)
Oxygen therapy improves cardiac index and pulmonary vascular resistance in patients with pulmonary hypertension
DH Roberts et al.
CHEST (2001)
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study
RN Channick et al.
LANCET (2001)
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease -: A randomized, controlled trial
DB Badesch et al.
ANNALS OF INTERNAL MEDICINE (2000)
分享论文
